These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 30022838)

  • 1. Immunohistochemical expression of hormone receptors, Ki-67, endoglin (CD105), claudins 3 and 4, MMP-2 and -9 in endometrial polyps and endometrial cancer type I.
    Peres GF; Spadoto-Dias D; Bueloni-Dias FN; Leite NJ; Elias LV; Domingues MAC; Padovani CR; Dias R
    Onco Targets Ther; 2018; 11():3949-3958. PubMed ID: 30022838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between redundant endometrium and endometrial polyps: a pilot study.
    Detti L; Peregrin-Alvarez I; Saed GM
    Minerva Obstet Gynecol; 2023 Jun; 75(3):219-226. PubMed ID: 34282611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clear cell carcinoma of the endometrium is characterized by a distinctive profile of p53, Ki-67, estrogen, and progesterone receptor expression.
    Lax SF; Pizer ES; Ronnett BM; Kurman RJ
    Hum Pathol; 1998 Jun; 29(6):551-8. PubMed ID: 9635673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The expression of the hormone receptors in the endometrium and endometrial polyps in postmenopausal women and its relationship to body mass index.
    Belisário MS; Vassallo J; Andrade LA; Alvarenga M; Pinto GA; Monteiro IM
    Maturitas; 2006 Jan; 53(1):114-8. PubMed ID: 15894442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selected immunohistochemical prognostic factors in endometrial cancer.
    Markova I; Duskova M; Lubusky M; Kudela M; Zapletalová J; Procházka M; Pilka R
    Int J Gynecol Cancer; 2010 May; 20(4):576-82. PubMed ID: 20686376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of clinical, ultrasonographic, hysteroscopic, and immunohistochemical parameters in differentiating endometrial polyps from endometrial cancer.
    Dias DS; Bueloni-Dias FN; Dias R; Nahás-Neto J; Petri Nahás EA; Leite NJ; Custódio Domingues MA; Bueno Angela SP; Padovani CR
    J Minim Invasive Gynecol; 2014; 21(2):296-302. PubMed ID: 24157565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of estrogen- and progesterone-receptor expression in endometrial polyps.
    Lopes RG; Baracat EC; de Albuquerque Neto LC; Ramos JF; Yatabe S; Depesr DB; Lippi UG
    J Minim Invasive Gynecol; 2007; 14(3):300-3. PubMed ID: 17478359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Steroid hormone receptor profile of premenopausal endometrial polyps.
    Zitao Liu ; Kuokkanen S; Pal L
    Reprod Sci; 2010 Apr; 17(4):377-83. PubMed ID: 20228382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of ER, PR, C-erbB-2 and Ki-67 in Endometrial Carcinoma and their Relationships with the Clinicopathological Features.
    Yu CG; Jiang XY; Li B; Gan L; Huang JF
    Asian Pac J Cancer Prev; 2015; 16(15):6789-94. PubMed ID: 26434913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ENDOMETRIAL POLYPS IN WOMEN OF REPRODUCTIVE AGE: CLINICAL AND PATHOGENE-TIC VARIATIONS.
    Kosei N; Zakharenko N; Herman D
    Georgian Med News; 2017 Dec; (273):16-22. PubMed ID: 29328024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of estrogen receptors alpha and beta, and progesterone receptors A and B in human mucinous carcinoma of the endometrium.
    Shabani N; Mylonas I; Jeschke U; Thaqi A; Kuhn C; Puchner T; Friese K
    Anticancer Res; 2007; 27(4A):2027-33. PubMed ID: 17649817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tamoxifen use and endometrial lesions: hysteroscopic, histological, and immunohistochemical findings in postmenopausal women with breast cancer.
    Dibi RP; Zettler CG; Pessini SA; Ayub AV; de Almeida SB; da Silveira GP
    Menopause; 2009; 16(2):293-300. PubMed ID: 19034048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [MMP-26 mRNA and estrogen receptor alpha co-expression in normal and pathological endometrium].
    Pilka R; Kudela M; Eriksson P; Casslén B
    Ceska Gynekol; 2005 Jan; 70(1):56-62. PubMed ID: 15779297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical expression of estrogen and progesterone receptors in endometrial polyps and adjacent endometrium in postmenopausal women.
    Sant'Ana de Almeida EC; Nogueira AA; Candido dos Reis FJ; Zambelli Ramalho LN; Zucoloto S
    Maturitas; 2004 Nov; 49(3):229-33. PubMed ID: 15488351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histologic effects of medroxyprogesterone acetate on endometrioid endometrial adenocarcinoma: a Gynecologic Oncology Group study.
    Zaino RJ; Brady WE; Todd W; Leslie K; Fischer EG; Horowitz NS; Mannel RS; Walker JL; Ivanovic M; Duska LR
    Int J Gynecol Pathol; 2014 Nov; 33(6):543-53. PubMed ID: 25272292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunohistochemical markers expression in hysteroscopy and hysterectomy specimens from endometrial cancer patients: comparison].
    Pilka R; Marková I; Dusková M; Zapletalová J; Tozzi M; Kudela M
    Ceska Gynekol; 2010 May; 75(3):165-70. PubMed ID: 20731294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Claudin 1 differentiates endometrioid and serous papillary endometrial adenocarcinoma.
    Sobel G; Németh J; Kiss A; Lotz G; Szabó I; Udvarhelyi N; Schaff Z; Páska C
    Gynecol Oncol; 2006 Nov; 103(2):591-8. PubMed ID: 16797678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IMMUNOHISTOCHEMISTRY IN ENDOMETRIAL HYPERPLASIA AND ENDOMETRIAL ADENOCARCINOMA.
    Socolov D; Socolov R; Lupascu IA; Rugina V; Gabia O; Garauleanu DM; Carauleanu A
    Rev Med Chir Soc Med Nat Iasi; 2016; 120(2):355-62. PubMed ID: 27483717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical characteristics of 42 cases of malignant endometrial polyps].
    Tang Z; Zhou R; Bao D; Liu C; Wei L
    Zhonghua Fu Chan Ke Za Zhi; 2014 Mar; 49(3):204-7. PubMed ID: 24820306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Supervised clustering of immunohistochemical markers to distinguish atypical endometrial hyperplasia from grade 1 endometrial cancer.
    Laas E; Ballester M; Cortez A; Gonin J; Daraï E; Graesslin O
    Gynecol Oncol; 2014 May; 133(2):205-10. PubMed ID: 24556060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.